Report Detail

Other Global Cancer Biological Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4598910
  • |
  • 02 July, 2024
  • |
  • Global
  • |
  • 136 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Cancer Biological Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cancer biological therapy is a type of treatment that uses the body's immune system to kill cancer cells. Cancer biological therapy can treat many types of cancer. It can prevent or slow tumor growth and prevent the spread of cancer. When cancer spreads, it's called metastatic cancer.
The Global Info Research report includes an overview of the development of the Cancer Biological Therapy industry chain, the market status of Hospitals (Monoclonal Antibodies, Vaccines), Diagnostic Laboratories (Monoclonal Antibodies, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Biological Therapy.
Regionally, the report analyzes the Cancer Biological Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Biological Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Biological Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Biological Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Biological Therapy market.
Regional Analysis: The report involves examining the Cancer Biological Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Biological Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Biological Therapy:
Company Analysis: Report covers individual Cancer Biological Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Biological Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Cancer Biological Therapy. It assesses the current state, advancements, and potential future developments in Cancer Biological Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Biological Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Biological Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Market segment by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by players, this report covers
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Biological Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Biological Therapy, with revenue, gross margin and global market share of Cancer Biological Therapy from 2019 to 2024.
Chapter 3, the Cancer Biological Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Biological Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Biological Therapy.
Chapter 13, to describe Cancer Biological Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cancer Biological Therapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cancer Biological Therapy by Type
    • 1.3.1 Overview: Global Cancer Biological Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cancer Biological Therapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Vaccines
    • 1.3.5 Cancer Growth Blockers
    • 1.3.6 Blood Cell Growth Factors
  • 1.4 Global Cancer Biological Therapy Market by Application
    • 1.4.1 Overview: Global Cancer Biological Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Diagnostic Laboratories
    • 1.4.4 Research & Academic Laboratories
    • 1.4.5 Pharmaceutical & Biotechnology Companies
  • 1.5 Global Cancer Biological Therapy Market Size & Forecast
  • 1.6 Global Cancer Biological Therapy Market Size and Forecast by Region
    • 1.6.1 Global Cancer Biological Therapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cancer Biological Therapy Market Size by Region, (2019-2030)
    • 1.6.3 North America Cancer Biological Therapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cancer Biological Therapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cancer Biological Therapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cancer Biological Therapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cancer Biological Therapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 ELI Lilly
    • 2.1.1 ELI Lilly Details
    • 2.1.2 ELI Lilly Major Business
    • 2.1.3 ELI Lilly Cancer Biological Therapy Product and Solutions
    • 2.1.4 ELI Lilly Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 ELI Lilly Recent Developments and Future Plans
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Cancer Biological Therapy Product and Solutions
    • 2.2.4 Sanofi Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sanofi Recent Developments and Future Plans
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Cancer Biological Therapy Product and Solutions
    • 2.3.4 Merck Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Merck Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Cancer Biological Therapy Product and Solutions
    • 2.4.4 Bayer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Cancer Biological Therapy Product and Solutions
    • 2.5.4 Roche Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Roche Recent Developments and Future Plans
  • 2.6 Novartis International
    • 2.6.1 Novartis International Details
    • 2.6.2 Novartis International Major Business
    • 2.6.3 Novartis International Cancer Biological Therapy Product and Solutions
    • 2.6.4 Novartis International Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novartis International Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Cancer Biological Therapy Product and Solutions
    • 2.7.4 Pfizer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 Bristol-Myers Squibb
    • 2.8.1 Bristol-Myers Squibb Details
    • 2.8.2 Bristol-Myers Squibb Major Business
    • 2.8.3 Bristol-Myers Squibb Cancer Biological Therapy Product and Solutions
    • 2.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.9 Seattle Genetics
    • 2.9.1 Seattle Genetics Details
    • 2.9.2 Seattle Genetics Major Business
    • 2.9.3 Seattle Genetics Cancer Biological Therapy Product and Solutions
    • 2.9.4 Seattle Genetics Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Seattle Genetics Recent Developments and Future Plans
  • 2.10 Amgen
    • 2.10.1 Amgen Details
    • 2.10.2 Amgen Major Business
    • 2.10.3 Amgen Cancer Biological Therapy Product and Solutions
    • 2.10.4 Amgen Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Amgen Recent Developments and Future Plans
  • 2.11 Takeda Pharmaceuticals
    • 2.11.1 Takeda Pharmaceuticals Details
    • 2.11.2 Takeda Pharmaceuticals Major Business
    • 2.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Product and Solutions
    • 2.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Takeda Pharmaceuticals Recent Developments and Future Plans
  • 2.12 GlaxoSmithKline
    • 2.12.1 GlaxoSmithKline Details
    • 2.12.2 GlaxoSmithKline Major Business
    • 2.12.3 GlaxoSmithKline Cancer Biological Therapy Product and Solutions
    • 2.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.13 Spectrum Pharmaceuticals
    • 2.13.1 Spectrum Pharmaceuticals Details
    • 2.13.2 Spectrum Pharmaceuticals Major Business
    • 2.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Product and Solutions
    • 2.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
  • 2.14 Celgene Corporation
    • 2.14.1 Celgene Corporation Details
    • 2.14.2 Celgene Corporation Major Business
    • 2.14.3 Celgene Corporation Cancer Biological Therapy Product and Solutions
    • 2.14.4 Celgene Corporation Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Celgene Corporation Recent Developments and Future Plans
  • 2.15 AstraZeneca, Plc.
    • 2.15.1 AstraZeneca, Plc. Details
    • 2.15.2 AstraZeneca, Plc. Major Business
    • 2.15.3 AstraZeneca, Plc. Cancer Biological Therapy Product and Solutions
    • 2.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 AstraZeneca, Plc. Recent Developments and Future Plans
  • 2.16 Otsuka
    • 2.16.1 Otsuka Details
    • 2.16.2 Otsuka Major Business
    • 2.16.3 Otsuka Cancer Biological Therapy Product and Solutions
    • 2.16.4 Otsuka Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Otsuka Recent Developments and Future Plans
  • 2.17 Eisai
    • 2.17.1 Eisai Details
    • 2.17.2 Eisai Major Business
    • 2.17.3 Eisai Cancer Biological Therapy Product and Solutions
    • 2.17.4 Eisai Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Eisai Recent Developments and Future Plans
  • 2.18 Abbvie
    • 2.18.1 Abbvie Details
    • 2.18.2 Abbvie Major Business
    • 2.18.3 Abbvie Cancer Biological Therapy Product and Solutions
    • 2.18.4 Abbvie Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Abbvie Recent Developments and Future Plans
  • 2.19 Incyte
    • 2.19.1 Incyte Details
    • 2.19.2 Incyte Major Business
    • 2.19.3 Incyte Cancer Biological Therapy Product and Solutions
    • 2.19.4 Incyte Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Incyte Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cancer Biological Therapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cancer Biological Therapy by Company Revenue
    • 3.2.2 Top 3 Cancer Biological Therapy Players Market Share in 2023
    • 3.2.3 Top 6 Cancer Biological Therapy Players Market Share in 2023
  • 3.3 Cancer Biological Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Cancer Biological Therapy Market: Region Footprint
    • 3.3.2 Cancer Biological Therapy Market: Company Product Type Footprint
    • 3.3.3 Cancer Biological Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cancer Biological Therapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cancer Biological Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cancer Biological Therapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cancer Biological Therapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cancer Biological Therapy Consumption Value by Type (2019-2030)
  • 6.2 North America Cancer Biological Therapy Consumption Value by Application (2019-2030)
  • 6.3 North America Cancer Biological Therapy Market Size by Country
    • 6.3.1 North America Cancer Biological Therapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cancer Biological Therapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cancer Biological Therapy Consumption Value by Type (2019-2030)
  • 7.2 Europe Cancer Biological Therapy Consumption Value by Application (2019-2030)
  • 7.3 Europe Cancer Biological Therapy Market Size by Country
    • 7.3.1 Europe Cancer Biological Therapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 7.3.3 France Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cancer Biological Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cancer Biological Therapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cancer Biological Therapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cancer Biological Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Cancer Biological Therapy Consumption Value by Region (2019-2030)
    • 8.3.2 China Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 8.3.5 India Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cancer Biological Therapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cancer Biological Therapy Consumption Value by Type (2019-2030)
  • 9.2 South America Cancer Biological Therapy Consumption Value by Application (2019-2030)
  • 9.3 South America Cancer Biological Therapy Market Size by Country
    • 9.3.1 South America Cancer Biological Therapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cancer Biological Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cancer Biological Therapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cancer Biological Therapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cancer Biological Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Cancer Biological Therapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cancer Biological Therapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cancer Biological Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cancer Biological Therapy Market Drivers
  • 11.2 Cancer Biological Therapy Market Restraints
  • 11.3 Cancer Biological Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cancer Biological Therapy Industry Chain
  • 12.2 Cancer Biological Therapy Upstream Analysis
  • 12.3 Cancer Biological Therapy Midstream Analysis
  • 12.4 Cancer Biological Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cancer Biological Therapy. Industry analysis & Market Report on Cancer Biological Therapy is a syndicated market report, published as Global Cancer Biological Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cancer Biological Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,683.08
    4,024.62
    5,366.16
    3,194.64
    4,791.96
    6,389.28
    551,197.20
    826,795.80
    1,102,394.40
    290,719.20
    436,078.80
    581,438.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report